Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)

NCT03062800 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

232

Enrollment

OTHER

Sponsor class

Conditions

Advanced Nsclc

Interventions

DRUG: Thalidomide
DRUG: pemetrexed
DRUG: cisplatin
DRUG: carboplatin

Sponsor

Qilu Hospital of Shandong University